Skip to main content

Table 1 Demographic profile of the subjects

From: Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis

 

All

Switch group

Ctrl group

P value

n

112

28

84

 

Age (Y)

60.2 ± 10.8

57.3 ± 12.0

61.2 ± 10.3

0.134

Gender (M/F)

55/57

14/14

41/43

0.913

Dialysis vintage (Y)

11.6 ± 6.5

12.1 ± 6.4

11.4 ± 6.6

0.604

Use of Psychotropic agents

39(35%)

12(43%)

27(32%)

0.594

Use of vitamin D analogues

46(41%)

14(50%)

32(38%)

0.267

Use of other phosphorus agents

93(83%)

24(86%)

69(82%)

0.660

   Precipitated calcium carbonate

58(51%)

21(75%)

36(43%)

0.001

   Lanthanum carbonate hydrate

12(11%)

3(11%)

9(11%)

 

   Precipitated calcium carbonate plus Lanthanum carbonate hydrate

24(21%)

0(0%)

24(28%)

 

   No agents

19(17%)

4(14%)

15(18%)

 

Use of Potassium absorbent

47(42%)

17(61%)

30(36%)

0.047

Use of laxative

31(28%)

5(18%)

26(31%)

0.179

Cardiovascular disease

36(32%)

9(32%)

27(32%)

1.000

Diabetes mellitus

28(25%)

8(29%)

20(24%)

0.614